Home NDC 50458-320 RISPERDAL
Product NDC 50458-320
11-digit product format 504580320
Labeler code 50458
Product ID 50458-320_b7f7983b-0d54-4910-9399-5b83d218bd74
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name risperidone
Dosage form TABLET
Route ORAL
Labeler Janssen Pharmaceuticals, Inc.
Application NDA020272
Marketing category NDA
Marketing start 1993-12-29
Substance RISPERIDONE
Active strength 2 mg/1
Pharmacologic classes Atypical Antipsychotic [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 12 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Snapshot, Source SHA-256 table Captured / source date Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 557ba5c1ecfa…9c80585c8c6e…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 7 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N020272-001 RISPERDAL RISPERIDONE 1MG TABLET / ORAL AB RLD, RS 1993-12-29 N020272-002 RISPERDAL RISPERIDONE 2MG TABLET / ORAL AB RLD 1993-12-29 N020272-003 RISPERDAL RISPERIDONE 3MG TABLET / ORAL AB RLD 1993-12-29 N020272-004 RISPERDAL RISPERIDONE 4MG TABLET / ORAL AB RLD 1993-12-29 N020272-005 RISPERDAL RISPERIDONE 5MG TABLET / ORAL 1993-12-29 N020272-007 RISPERDAL RISPERIDONE 0.5MG TABLET / ORAL AB RLD 1999-01-27 N020272-008 RISPERDAL RISPERIDONE 0.25MG TABLET / ORAL AB RLD 1999-05-10
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 6 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 8 · 308 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 N020272-001 RISPERDAL 1MG TABLET / ORAL AB RLD, RS 1993-12-29 c2088c7a36db…2026-10-15 13:18:30 2026-09 N020272-002 RISPERDAL 2MG TABLET / ORAL AB RLD 1993-12-29 c2088c7a36db…2026-10-15 13:18:30 2026-09 N020272-003 RISPERDAL 3MG TABLET / ORAL AB RLD 1993-12-29 c2088c7a36db…2026-10-15 13:18:30 2026-09 N020272-004 RISPERDAL 4MG TABLET / ORAL AB RLD 1993-12-29 c2088c7a36db…2026-10-15 13:18:30 2026-09 N020272-005 RISPERDAL 5MG TABLET / ORAL 1993-12-29 c2088c7a36db…2026-10-15 13:18:30 2026-09 N020272-007 RISPERDAL 0.5MG TABLET / ORAL AB RLD 1999-01-27 c2088c7a36db…2026-10-15 13:18:30 2026-09 N020272-008 RISPERDAL 0.25MG TABLET / ORAL AB RLD 1999-05-10 c2088c7a36db…2026-09-14 22:38:34 2026-08 N020272-001 RISPERDAL 1MG TABLET / ORAL AB RLD, RS 1993-12-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 N020272-002 RISPERDAL 2MG TABLET / ORAL AB RLD 1993-12-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 N020272-003 RISPERDAL 3MG TABLET / ORAL AB RLD 1993-12-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 N020272-004 RISPERDAL 4MG TABLET / ORAL AB RLD 1993-12-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 N020272-005 RISPERDAL 5MG TABLET / ORAL 1993-12-29 84e616aacf4f…2026-09-14 22:38:34 2026-08 N020272-007 RISPERDAL 0.5MG TABLET / ORAL AB RLD 1999-01-27 84e616aacf4f…2026-09-14 22:38:34 2026-08 N020272-008 RISPERDAL 0.25MG TABLET / ORAL AB RLD 1999-05-10 84e616aacf4f…2026-08-18 06:07:40 2026-07 N020272-001 RISPERDAL 1MG TABLET / ORAL AB RLD, RS 1993-12-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N020272-002 RISPERDAL 2MG TABLET / ORAL AB RLD 1993-12-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N020272-003 RISPERDAL 3MG TABLET / ORAL AB RLD 1993-12-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N020272-004 RISPERDAL 4MG TABLET / ORAL AB RLD 1993-12-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N020272-005 RISPERDAL 5MG TABLET / ORAL 1993-12-29 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N020272-007 RISPERDAL 0.5MG TABLET / ORAL AB RLD 1999-01-27 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N020272-008 RISPERDAL 0.25MG TABLET / ORAL AB RLD 1999-05-10 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N020272-001 RISPERDAL 1MG TABLET / ORAL AB RLD, RS 1993-12-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020272-002 RISPERDAL 2MG TABLET / ORAL AB RLD 1993-12-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020272-003 RISPERDAL 3MG TABLET / ORAL AB RLD 1993-12-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020272-004 RISPERDAL 4MG TABLET / ORAL AB RLD 1993-12-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020272-005 RISPERDAL 5MG TABLET / ORAL 1993-12-29 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020272-007 RISPERDAL 0.5MG TABLET / ORAL AB RLD 1999-01-27 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020272-008 RISPERDAL 0.25MG TABLET / ORAL AB RLD 1999-05-10 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020272-001 RISPERDAL 1MG TABLET / ORAL AB RLD, RS 1993-12-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020272-002 RISPERDAL 2MG TABLET / ORAL AB RLD 1993-12-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020272-003 RISPERDAL 3MG TABLET / ORAL AB RLD 1993-12-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020272-004 RISPERDAL 4MG TABLET / ORAL AB RLD 1993-12-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020272-005 RISPERDAL 5MG TABLET / ORAL 1993-12-29 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020272-007 RISPERDAL 0.5MG TABLET / ORAL AB RLD 1999-01-27 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020272-008 RISPERDAL 0.25MG TABLET / ORAL AB RLD 1999-05-10 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N020272-001 RISPERDAL 1MG TABLET / ORAL AB RLD, RS 1993-12-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020272-002 RISPERDAL 2MG TABLET / ORAL AB RLD 1993-12-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020272-003 RISPERDAL 3MG TABLET / ORAL AB RLD 1993-12-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020272-004 RISPERDAL 4MG TABLET / ORAL AB RLD 1993-12-29 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020272-005 RISPERDAL 5MG TABLET / ORAL 1993-12-29 6a471c1ec25d…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 7 · 264 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base RISPERDAL
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength RISPERIDONE 2 mg/1
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 50458-320-01 RISPERDAL 10 in 1 BLISTER PACK TABLET 10 42 50458-320-01 RISPERDAL 10 in 1 BOX, UNIT-DOSE TABLET 10 42 50458-320-06 RISPERDAL 60 in 1 BOTTLE TABLET 60 42 50458-320-50 RISPERDAL 500 in 1 BOTTLE TABLET 500 42
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded risperidone ACTIVE INGREDIENT L6UH7ZF8HC RISPERDAL (RISPERIDONE) TABLET RISPERDAL M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING RISPERDAL (RISPERIDONE) SOLUTION [JANSSEN PHARMACEUTICALS, INC.] 15 risperidone ACTIVE MOIETY L6UH7ZF8HC RISPERDAL (RISPERIDONE) TABLET RISPERDAL M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING RISPERDAL (RISPERIDONE) SOLUTION [JANSSEN PHARMACEUTICALS, INC.] 15 Aluminum Oxide INACTIVE INGREDIENT LMI26O6933 RISPERDAL (RISPERIDONE) TABLET RISPERDAL M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING RISPERDAL (RISPERIDONE) SOLUTION [JANSSEN PHARMACEUTICALS, INC.] 15 anhydrous lactose INACTIVE INGREDIENT 3SY5LH9PMK RISPERDAL (RISPERIDONE) TABLET RISPERDAL M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING RISPERDAL (RISPERIDONE) SOLUTION [JANSSEN PHARMACEUTICALS, INC.] 15 aspartame INACTIVE INGREDIENT Z0H242BBR1 RISPERDAL (RISPERIDONE) TABLET RISPERDAL M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING RISPERDAL (RISPERIDONE) SOLUTION [JANSSEN PHARMACEUTICALS, INC.] 15 benzoic acid INACTIVE INGREDIENT 8SKN0B0MIM RISPERDAL (RISPERIDONE) TABLET RISPERDAL M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING RISPERDAL (RISPERIDONE) SOLUTION [JANSSEN PHARMACEUTICALS, INC.] 15 CARBOMER HOMOPOLYMER TYPE C (ALLYL PENTAERYTHRITOL CROSSLINKED) INACTIVE INGREDIENT 4Q93RCW27E RISPERDAL (RISPERIDONE) TABLET RISPERDAL M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING RISPERDAL (RISPERIDONE) SOLUTION [JANSSEN PHARMACEUTICALS, INC.] 15 cellulose, microcrystalline INACTIVE INGREDIENT OP1R32D61U RISPERDAL (RISPERIDONE) TABLET RISPERDAL M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING RISPERDAL (RISPERIDONE) SOLUTION [JANSSEN PHARMACEUTICALS, INC.] 15 D&C Yellow No. 10 INACTIVE INGREDIENT 35SW5USQ3G RISPERDAL (RISPERIDONE) TABLET RISPERDAL M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING RISPERDAL (RISPERIDONE) SOLUTION [JANSSEN PHARMACEUTICALS, INC.] 15 FD&C Blue No. 2 INACTIVE INGREDIENT L06K8R7DQK RISPERDAL (RISPERIDONE) TABLET RISPERDAL M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING RISPERDAL (RISPERIDONE) SOLUTION [JANSSEN PHARMACEUTICALS, INC.] 15 FD&C Yellow No. 6 INACTIVE INGREDIENT H77VEI93A8 RISPERDAL (RISPERIDONE) TABLET RISPERDAL M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING RISPERDAL (RISPERIDONE) SOLUTION [JANSSEN PHARMACEUTICALS, INC.] 15 ferric oxide red INACTIVE INGREDIENT 1K09F3G675 RISPERDAL (RISPERIDONE) TABLET RISPERDAL M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING RISPERDAL (RISPERIDONE) SOLUTION [JANSSEN PHARMACEUTICALS, INC.] 15 ferric oxide yellow INACTIVE INGREDIENT EX438O2MRT RISPERDAL (RISPERIDONE) TABLET RISPERDAL M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING RISPERDAL (RISPERIDONE) SOLUTION [JANSSEN PHARMACEUTICALS, INC.] 15 gelatin INACTIVE INGREDIENT 2G86QN327L RISPERDAL (RISPERIDONE) TABLET RISPERDAL M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING RISPERDAL (RISPERIDONE) SOLUTION [JANSSEN PHARMACEUTICALS, INC.] 15 glycine INACTIVE INGREDIENT TE7660XO1C RISPERDAL (RISPERIDONE) TABLET RISPERDAL M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING RISPERDAL (RISPERIDONE) SOLUTION [JANSSEN PHARMACEUTICALS, INC.] 15 hypromelloses INACTIVE INGREDIENT 3NXW29V3WO RISPERDAL (RISPERIDONE) TABLET RISPERDAL M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING RISPERDAL (RISPERIDONE) SOLUTION [JANSSEN PHARMACEUTICALS, INC.] 15 magnesium stearate INACTIVE INGREDIENT 70097M6I30 RISPERDAL (RISPERIDONE) TABLET RISPERDAL M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING RISPERDAL (RISPERIDONE) SOLUTION [JANSSEN PHARMACEUTICALS, INC.] 15 mannitol INACTIVE INGREDIENT 3OWL53L36A RISPERDAL (RISPERIDONE) TABLET RISPERDAL M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING RISPERDAL (RISPERIDONE) SOLUTION [JANSSEN PHARMACEUTICALS, INC.] 15 peppermint oil INACTIVE INGREDIENT AV092KU4JH RISPERDAL (RISPERIDONE) TABLET RISPERDAL M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING RISPERDAL (RISPERIDONE) SOLUTION [JANSSEN PHARMACEUTICALS, INC.] 15 propylene glycol INACTIVE INGREDIENT 6DC9Q167V3 RISPERDAL (RISPERIDONE) TABLET RISPERDAL M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING RISPERDAL (RISPERIDONE) SOLUTION [JANSSEN PHARMACEUTICALS, INC.] 15 silicon dioxide INACTIVE INGREDIENT ETJ7Z6XBU4 RISPERDAL (RISPERIDONE) TABLET RISPERDAL M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING RISPERDAL (RISPERIDONE) SOLUTION [JANSSEN PHARMACEUTICALS, INC.] 15 sodium hydroxide INACTIVE INGREDIENT 55X04QC32I RISPERDAL (RISPERIDONE) TABLET RISPERDAL M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING RISPERDAL (RISPERIDONE) SOLUTION [JANSSEN PHARMACEUTICALS, INC.] 15 sodium lauryl sulfate INACTIVE INGREDIENT 368GB5141J RISPERDAL (RISPERIDONE) TABLET RISPERDAL M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING RISPERDAL (RISPERIDONE) SOLUTION [JANSSEN PHARMACEUTICALS, INC.] 15 starch, corn INACTIVE INGREDIENT O8232NY3SJ RISPERDAL (RISPERIDONE) TABLET RISPERDAL M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING RISPERDAL (RISPERIDONE) SOLUTION [JANSSEN PHARMACEUTICALS, INC.] 15 talc INACTIVE INGREDIENT 7SEV7J4R1U RISPERDAL (RISPERIDONE) TABLET RISPERDAL M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING RISPERDAL (RISPERIDONE) SOLUTION [JANSSEN PHARMACEUTICALS, INC.] 15 tartaric acid INACTIVE INGREDIENT W4888I119H RISPERDAL (RISPERIDONE) TABLET RISPERDAL M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING RISPERDAL (RISPERIDONE) SOLUTION [JANSSEN PHARMACEUTICALS, INC.] 15 titanium dioxide INACTIVE INGREDIENT 15FIX9V2JP RISPERDAL (RISPERIDONE) TABLET RISPERDAL M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING RISPERDAL (RISPERIDONE) SOLUTION [JANSSEN PHARMACEUTICALS, INC.] 15 water INACTIVE INGREDIENT 059QF0KO0R RISPERDAL (RISPERIDONE) TABLET RISPERDAL M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING RISPERDAL (RISPERIDONE) SOLUTION [JANSSEN PHARMACEUTICALS, INC.] 15 xanthan gum INACTIVE INGREDIENT TTV12P4NEE RISPERDAL (RISPERIDONE) TABLET RISPERDAL M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING RISPERDAL (RISPERIDONE) SOLUTION [JANSSEN PHARMACEUTICALS, INC.] 15 risperidone ACTIVE INGREDIENT L6UH7ZF8HC RISPERDAL (RISPERIDONE) TABLET [PD-RX PHARMACEUTICALS, INC.] 12 risperidone ACTIVE MOIETY L6UH7ZF8HC RISPERDAL (RISPERIDONE) TABLET [PD-RX PHARMACEUTICALS, INC.] 12 Aluminum Oxide INACTIVE INGREDIENT LMI26O6933 RISPERDAL (RISPERIDONE) TABLET [PD-RX PHARMACEUTICALS, INC.] 12 anhydrous lactose INACTIVE INGREDIENT 3SY5LH9PMK RISPERDAL (RISPERIDONE) TABLET [PD-RX PHARMACEUTICALS, INC.] 12 cellulose, microcrystalline INACTIVE INGREDIENT OP1R32D61U RISPERDAL (RISPERIDONE) TABLET [PD-RX PHARMACEUTICALS, INC.] 12 FD&C Yellow No. 6 INACTIVE INGREDIENT H77VEI93A8 RISPERDAL (RISPERIDONE) TABLET [PD-RX PHARMACEUTICALS, INC.] 12 hypromelloses INACTIVE INGREDIENT 3NXW29V3WO RISPERDAL (RISPERIDONE) TABLET [PD-RX PHARMACEUTICALS, INC.] 12 magnesium stearate INACTIVE INGREDIENT 70097M6I30 RISPERDAL (RISPERIDONE) TABLET [PD-RX PHARMACEUTICALS, INC.] 12 propylene glycol INACTIVE INGREDIENT 6DC9Q167V3 RISPERDAL (RISPERIDONE) TABLET [PD-RX PHARMACEUTICALS, INC.] 12 silicon dioxide INACTIVE INGREDIENT ETJ7Z6XBU4 RISPERDAL (RISPERIDONE) TABLET [PD-RX PHARMACEUTICALS, INC.] 12 sodium lauryl sulfate INACTIVE INGREDIENT 368GB5141J RISPERDAL (RISPERIDONE) TABLET [PD-RX PHARMACEUTICALS, INC.] 12 starch, corn INACTIVE INGREDIENT O8232NY3SJ RISPERDAL (RISPERIDONE) TABLET [PD-RX PHARMACEUTICALS, INC.] 12 talc INACTIVE INGREDIENT 7SEV7J4R1U RISPERDAL (RISPERIDONE) TABLET [PD-RX PHARMACEUTICALS, INC.] 12 titanium dioxide INACTIVE INGREDIENT 15FIX9V2JP RISPERDAL (RISPERIDONE) TABLET [PD-RX PHARMACEUTICALS, INC.] 12
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 50458-320 RISPERDAL (RISPERIDONE) TABLET RISPERDAL M-TAB (RISPERIDONE) TABLET, ORALLY DISINTEGRATING RISPERDAL (RISPERIDONE) SOLUTION [JANSSEN PHARMACEUTICALS, INC.] 40 Current NDC, Legacy NDC, 4 package rows 20250228_7e117c7e-02fc-4343-92a1-230061dfc5e0.zip
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 50458-320-01 50458032001 10 BLISTER PACK in 1 BOX, UNIT-DOSE (50458-320-01) > 10 TABLET in 1 BLISTER PACK 10 blister pack 1993-12-29 0000-00-00 No No Current 50458-320-06 50458032006 60 TABLET in 1 BOTTLE (50458-320-06) 60 tablet 1993-12-29 0000-00-00 No No Current 50458-320-50 50458032050 500 in 1 BOTTLE Historical